Thomas Pike - 09 Jan 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Pres & CEO Clinical Business
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Thomas Pike
Issuer symbol
LH
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4
Filing time
11 Jan 2023, 12:42:40 UTC
Previous filing
02 Dec 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Award $0 +16,960 $0.000000 16,960 09 Jan 2023 Common Stock 16,960 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 The Restricted Stock Units vest in three equal annual installments beginning on January 9, 2024.